Loading clinical trials...
Loading clinical trials...
TRIGGER 1 is a previous study that evaluate the immunological risk of pregnancy in women with lung transplants in France, whose pregnancy has ended between January 1, 2012 and December 31, 2021. The p...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nantes University Hospital
Collaborators
NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more
NCT06397794 · Lyme Disease, Post Treatment Lyme Disease, and more
NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more
NCT07233278 · Recurrent Pregnancy Loss(RPL), Anxiety
NCT05444283 · Recurrent Pregnancy Loss
Nantes University Hospital
Nantes, Loire Atlantique
Bordeaux University Hospital
Bordeaux
Grenoble University Hospital
Grenoble
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions